Homœopathic Links 2021; 34(03): 191-198
DOI: 10.1055/s-0041-1735489
Original Article

Homoeopathic Treatment in Hypothyroidism—An Open-Label, Prospective, Single-Arm, Clinical Trial

Aniket Singha Ray
1   Department of Organon of Medicine and Homoeopathic Philosophy, D.N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Subhasish Ganguly
1   Department of Organon of Medicine and Homoeopathic Philosophy, D.N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Shyamal Kumar Mukherjee
2   Principal, D.N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Pallavi Hazra
1   Department of Organon of Medicine and Homoeopathic Philosophy, D.N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
1   Department of Organon of Medicine and Homoeopathic Philosophy, D.N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
,
Arunava Nath
3   Deptartment of Forensic Medicine & Toxicology, Pratap Chandra Memorial Homoeopathic Hospital and College, Kolkata, West Bengal, India
,
Munmun Koley
4   Department of Organon of Medicine and Homoeopathic Philosophy, National Homoeopathic Medical College, Lucknow, Uttar Pradesh, India
,
Subhranil Saha
5   Department of Repertory, D.N.De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India
› Author Affiliations

Abstract

Background Hypothyroidism is one of the most common endocrinal disorders in India and its incidence is gradually increasing. A preliminary clinical trial was conducted to assess the probable role of individualised homoeopathic (IH) medicines in hypothyroidism with the assessment of hormonal titre (serum thyroid-stimulating hormone [TSH] and free T4) and symptomatic improvement.

Methods An open-label, prospective, single-arm trial was conducted on 40 patients suffering from hypothyroidism at the outpatient of D. N. De Homeopathic Medical College and Hospital, West Bengal, India, and treated with IH. Serum TSH and FT4 were considered as the primary outcomes and Zuleswki's clinical scoring (ZCS) and thyroid symptom questionnaire (TSQ) as the secondary outcomes, measured at baseline and after 3 months of treatment. Intention-to-treat sample was analysed in the end by paired t-tests.

Results Total 58 patients were screened, of which 40 patients were enrolled; 4 patients dropped out, 36 patients completed the trial. Mean age was 44 years (standard deviation: 13.6), and majority of the patients were female (87.5%). Improvement in both primary and secondary outcomes was statistically significant (p <0.001, paired t-tests), TSH (mean reduction: 2.7, 95% confidence interval [CI]: 1.9–3.6, p = 0.001), FT4 (mean increase: −0.2, 95% CI: −0.3 to −0.2, p = 0.001), ZCS (mean reduction: 3.7, 95% CI: 2.9–4.6, p = 0.001), and TSQ (mean reduction: 2.9, 95% CI: 2.1–3.6, p = 0.001). Most frequently used medicines were Sulphur (20%), Pulsatilla nigricans (12.5%), Iodium (10%), Phosphorus (10%), and Natrum muriaticum (7.5%).

Conclusion This study showed promising treatment effects of IH in hypothyroidism. Randomised trials are warranted (Trial registration: CTRI/2018/11/016451; UTN: U1111–1223–2292).

Authors' Contribution

ASR, SG, SKM, PH, and SD were involved in concept, literature search, clinical study, data acquisition, data interpretation, and preparation of the article; AN, MK, and SS were involved in concept, literature search, design, data interpretation, statistical analysis, and preparation of the article. All the authors reviewed and approved the final paper.


Ethical Approval

The study protocol was approved by the IEC (Ref. No. DHC/Aca(PG)29/14/861/18) dated 13 September 2018 and was registered prospectively in the Clinical Trials Registry—India (Trial registration: CTRI/2018/11/016451; UTN: U1111–1223–2292).


Financial Support

Nil.




Publication History

Article published online:
10 December 2021

© 2021. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Human Diseases in ICD-11 Classification by World Health Organization. [Accessed September 20, 2020]. Available from: https://www.icd10data.com/ICD10CM/Codes/E00-E89/E00-E07/E03-/E03.9
  • 2 Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet 2017; 390 (10101): 1550-1562
  • 3 Kostoglou-Athanassiou I, Ntalles K. Hypothyroidism - new aspects of an old disease. Hippokratia 2010; 14 (02) 82-87
  • 4 Hollowell JG, Staehling NW, Flanders WD. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87 (02) 489-499
  • 5 Hoogendoorn EH, Hermus AR, de Vegt F. et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006; 52 (01) 104-111
  • 6 Bemben DA, Hamm RM, Morgan L, Winn P, Davis A, Barton E. Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. J Fam Pract 1994; 38 (06) 583-588
  • 7 Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab 2013; 17 (04) 647-652
  • 8 Chauhan VK, Manchanda RK, Narang A. et al. Efficacy of homeopathic intervention in subclinical hypothyroidism with or without autoimmune thyroiditis in children: an exploratory randomized control study. Homeopathy 2014; 103 (04) 224-231
  • 9 Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997; 82 (03) 771-776
  • 10 Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002; 57 (05) 577-585
  • 11 Kalra S, Agarwal N, Aggarwal R. et al. Patient-centered management of hypothyroidism. Indian J Endocrinol Metab 2017; 21 (03) 475-477
  • 12 Kumar P, Khandelwal D, Mittal S. et al. Knowledge, awareness, practices and adherence to treatment of patients with primary hypothyroidism in Delhi. Indian J Endocrinol Metab 2017; 21 (03) 429-433
  • 13 Sangita A, Jadav SB. Efficacy of homoeopathic thyroidinum 3x in hypothyroidism in both sexes between age group 20 to 40 years. Int J Sci Res 2019; 8: 800-809
  • 14 Ghare P, Jadhav AB, Patil AV. A clinical study to see the effect of thyroidinum, a homoeopathic preparation on thyroid peroxidase antibody in subclinical hypothyroidism of age group between 18–70 years. Int J Health Sci Res 2020; 10: 18-22
  • 15 Chauhan VK, Manchanda RK, Narang A. et al. Prevalence of thyroid disorders in school children in Delhi – post iodization scenario. Indian J Res Homoeopathy 2009; 3: 29-33
  • 16 Schmidt JM, Ostermayr B. Does a homeopathic ultramolecular dilution of Thyroidinum 30cH affect the rate of body weight reduction in fasting patients? A randomised placebo-controlled double-blind clinical trial. Homeopathy 2002; 91 (04) 197-206
  • 17 Guedes JRP, Ferreira CM, Guimarães HMB, Saldiva PH, Capelozzi VL. Homeopathically prepared dilution of Rana catesbeiana thyroid glands modifies its rate of metamorphosis. Homeopathy 2004; 93 (03) 132-137